Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
NCT00985517
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Parkinson's Disease
Interventions
BIOLOGICAL:
CERE-120: Adeno-Associated Virus Delivery of Neurturin
PROCEDURE:
Sham Surgery
Sponsor
Sangamo Therapeutics